In testing of reference samples from several batches, results outside the quality specification were found for atomoxetine content and, for one batch, non-compliance in mass uniformity, which constitutes a real and direct risk to patients’ health or life. Potential effects: reduced treatment efficacy, possible worsening of disease symptom control.
Download the app and stay informed
Get instant notifications about recalled products and protect your family.
Important Information
Do not use the specified batches of the medicine. Check the batch number on the packaging; if you possess a product from these batches, return it to the pharmacy and consult your doctor regarding furt...
The distribution of specified batches of Konaten was suspended throughout the country, and the decision was given immediate enforceability. The manufacturer re-tested the batches and halted the manufa...
If you feel unwell after consuming this product, contact your doctor or call the poison control center.
FAQ
Related